Skip to main content

Articles

Page 6 of 6

  1. The resurgence of interest in cancer metabolism has linked alterations in the regulation and exploitation of metabolic pathways with an anabolic phenotype that increases biomass production for the replication ...

    Authors: Jason A Zastre, Rebecca L Sweet, Bradley S Hanberry and Star Ye

    Citation: Cancer & Metabolism 2013 1:16

    Content type: Review

    Published on:

  2. Multiple myeloma (MM) is a fatal plasma cell malignancy exhibiting enhanced glucose consumption associated with an aerobic glycolytic phenotype (i.e., the Warburg effect). We have previously demonstrated that ...

    Authors: Javelin C Cheng, Samuel K McBrayer, Cristian Coarfa, Sevim Dalva-Aydemir, Preethi H Gunaratne, John D Carpten, Jonathan K Keats, Steven T Rosen and Mala Shanmugam

    Citation: Cancer & Metabolism 2013 1:14

    Content type: Rapid Communication

    Published on:

  3. Loss of function of fumarate hydratase (FH), the mitochondrial tumor suppressor and tricarboxylic acid (TCA) cycle enzyme, is associated with a highly malignant form of papillary and collecting duct renal cell...

    Authors: Liang Zheng, Elaine D MacKenzie, Saadia A Karim, Ann Hedley, Karen Blyth, Gabriela Kalna, David G Watson, Peter Szlosarek, Christian Frezza and Eyal Gottlieb

    Citation: Cancer & Metabolism 2013 1:12

    Content type: Research

    Published on:

  4. Aerobic glycolysis, namely the Warburg effect, is the main hallmark of cancer cells. Mitochondrial respiratory dysfunction has been proposed to be one of the major causes for such glycolytic shift. This hypoth...

    Authors: Claudia Calabrese, Luisa Iommarini, Ivana Kurelac, Maria Antonietta Calvaruso, Mariantonietta Capristo, Pier-Luigi Lollini, Patrizia Nanni, Christian Bergamini, Giordano Nicoletti, Carla De Giovanni, Anna Ghelli, Valentina Giorgio, Mariano Francesco Caratozzolo, Flaviana Marzano, Caterina Manzari, Christine M Betts…

    Citation: Cancer & Metabolism 2013 1:11

    Content type: Research

    Published on:

  5. Calorie restriction (CR) is one of the most potent broadly acting dietary interventions for inducing weight loss and for inhibiting cancer in experimental models. Translation of the mechanistic lessons learned...

    Authors: Stephen D Hursting, Sarah M Dunlap, Nikki A Ford, Marcie J Hursting and Laura M Lashinger

    Citation: Cancer & Metabolism 2013 1:10

    Content type: Review

    Published on:

  6. The p53 tumor suppressor protein is a transcription factor that initiates transcriptional programs aimed at inhibiting carcinogenesis. p53 represses metabolic pathways that support tumor development (such as g...

    Authors: Ido Goldstein, Keren Yizhak, Shalom Madar, Naomi Goldfinger, Eytan Ruppin and Varda Rotter

    Citation: Cancer & Metabolism 2013 1:9

    Content type: Rapid Communication

    Published on:

  7. Cancer cells engage in aerobic glycolysis and glutaminolysis to fulfill their biosynthetic and energetic demands in part by activating MYC. Previous reports have characterized metabolic changes in proliferating c...

    Authors: Elena Anso, Andrew R Mullen, Dean W Felsher, José M Matés, Ralph J DeBerardinis and Navdeep S Chandel

    Citation: Cancer & Metabolism 2013 1:7

    Content type: Rapid Communication

    Published on:

  8. Metabolic reprogramming is a key event in tumorigenesis to support cell growth, and cancer cells frequently become both highly glycolytic and glutamine dependent. Similarly, T lymphocytes (T cells) modify thei...

    Authors: Andrew N Macintyre and Jeffrey C Rathmell

    Citation: Cancer & Metabolism 2013 1:5

    Content type: Review

    Published on:

  9. Tissue imaging of treatment-induced metabolic changes is useful for optimizing cancer therapies, but commonly used methods require trade-offs between assay sensitivity and spatial resolution. Nanostructure-Ini...

    Authors: Peter J O’Brien, Michelle Lee, Mary E Spilker, Cathy C Zhang, Zhengming Yan, Timothy C Nichols, Wenlin Li, Caroline H Johnson, Gary J Patti and Gary Siuzdak

    Citation: Cancer & Metabolism 2013 1:4

    Content type: Methodology

    Published on:

  10. Regulation of lipid metabolism via activation of sterol regulatory element binding proteins (SREBPs) has emerged as an important function of the Akt/mTORC1 signaling axis. Although the contribution of dysregul...

    Authors: Beatrice Griffiths, Caroline A Lewis, Karim Bensaad, Susana Ros, Qifeng Zhang, Emma C Ferber, Sofia Konisti, Barrie Peck, Heike Miess, Philip East, Michael Wakelam, Adrian L Harris and Almut Schulze

    Citation: Cancer & Metabolism 2013 1:3

    Content type: Research

    Published on:

  11. While aerobic glycolysis is linked to unconstrained proliferation in cancer, less is known about its physiological role. Why this metabolic program that promotes tumor growth is preserved in the genome has thu...

    Authors: Timothy R Gershon, Andrew J Crowther, Andrey Tikunov, Idoia Garcia, Ryan Annis, Hong Yuan, C Ryan Miller, Jeffrey Macdonald, James Olson and Mohanish Deshmukh

    Citation: Cancer & Metabolism 2013 1:2

    Content type: Research

    Published on:

Impact of COVID-19

COVID-19 © elipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process. We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.

Thumbnail image by Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license.

Annual Journal Metrics

  • Speed
    65 days to first decision for reviewed manuscripts only
    59 days to first decision for all manuscripts
    135 days from submission to acceptance
    35 days from acceptance to publication

    Citation Impact

    5.033 - 2 Year Impact Factor
    0.583 - Immediacy Index

    Usage 
    140,853 Downloads
    210 Altmetric Mentions